Advertisement

Topics

Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024

13:45 EST 8 Nov 2017 | BioMedReports - Blog

CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024

NEXT ARTICLE

More From BioPortfolio on "Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024"

Advertisement
Quick Search
Advertisement
Advertisement